A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation

BACKGROUND: New-onset diabetes mellitus after transplantation (NODAT), a frequent and serious complication after transplantation, is associated with decreased graft and patient survival. Currently, it is diagnosed and treated primarily according to existing guidelines for type II diabetes. To date,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Haidinger, Michael, Werzowa, Johannes, Voigt, Hans-Christian, Pleiner, Johannes, Stemer, Gunar, Hecking, Manfred, Döller, Dominik, Hörl, Walter H, Weichhart, Thomas, Säemann, Marcus D
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2010
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2984585/
https://ncbi.nlm.nih.gov/pubmed/20925938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-11-91
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia